Zymeworks CFO Dr. Astle Exits with Severance Package
Has issued an update. Zymeworks Inc. has announced the departure of Dr. Christopher Astle as Senior Vice President and Chief F...
Stay updated with breaking news from Christopher Astle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Has issued an update. Zymeworks Inc. has announced the departure of Dr. Christopher Astle as Senior Vice President and Chief F...
NEW YORK, April 4, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. . Such investors are advised to contact Danielle Peyton at...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. ("Zymeworks" or the "Company") (NASDAQ: ZYME). Such investors...
Zymeworks Inc. (NYSE:ZYME – Get Free Report) shares hit a new 52-week high on Tuesday . The stock traded as high as $12.71 and last traded at $12.52, with a volume of 90247 shares changing hands. The stock had previously closed at $12.37. Zymeworks Stock Performance The firm has a fifty day simple moving average […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report) CFO Christopher Astle sold 4,563 shares of the firm’s stock in a transaction that occurred on Friday, January 5th. The shares were sold at an average price of $10.65, for a total transaction of $48,595.95. Following the completion of the sale, the chief financial officer now owns 7,934 […]